Asia Pacific Uterine Fibroid Treatment Device Market Size & Outlook
Asia Pacific uterine fibroid treatment device market, 2016-2027 (US$M)
Related Markets
Asia Pacific uterine fibroid treatment device market highlights
- The Asia Pacific uterine fibroid treatment device market generated a revenue of USD 596.3 million in 2020.
- The market is expected to grow at a CAGR of 10.6% from 2021 to 2027.
- In terms of segment, surgical technologies was the largest revenue generating technology in 2020.
- Ablation Techniques is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2021 to 2027.
Asia Pacific data book summary
| Market revenue in 2020 | USD 596.3 million |
| Market revenue in 2027 | USD 1,203.7 million |
| Growth rate | 10.6% (CAGR from 2020 to 2027) |
| Largest segment | Surgical technologies |
| Fastest growing segment | Ablation Techniques |
| Historical data covered | 2016 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Surgical Technologies, Ablation Techniques, Laparoscopic Techniques, Embolization Techniques |
| Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Stryker Corp, CooperSurgical, Hologic Inc, Lumenis, InSightec |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 12.0% of the global uterine fibroid treatment device market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2027.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,203.7 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Uterine Fibroid Treatment Device Market Scope
Uterine Fibroid Treatment Device Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific uterine fibroid treatment device market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to uterine fibroid treatment device market will help companies and investors design strategic landscapes.
Surgical technologies was the largest segment with a revenue share of 39.19% in 2020. Horizon Databook has segmented the Asia Pacific uterine fibroid treatment device market based on surgical technologies, ablation techniques, laparoscopic techniques, embolization techniques covering the revenue growth of each sub-segment from 2016 to 2027.
Reasons to subscribe to Asia Pacific uterine fibroid treatment device market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific uterine fibroid treatment device market databook
-
Our clientele includes a mix of uterine fibroid treatment device market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific uterine fibroid treatment device market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific uterine fibroid treatment device market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific uterine fibroid treatment device market size, by country, 2016-2027 (US$M)
Asia Pacific Uterine Fibroid Treatment Device Market Share, 2020 & 2027 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
